Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Bristol-Myers Squibb (BMY)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2021 Q2 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2021 Q1 | 40,241 | 0.02 | Add 78.46% | <0.01 | $63.12 | $2,540,000 | SEC |
| 2020 Q4 | 22,549 | 0.02 | Add 214.62% | 0.01 | $62.04 | $1,399,000 | SEC |
| 2020 Q3 | 7,167 | 0.01 | Reduce 89.04% | 0.07 | $60.28 | $432,000 | SEC |
| 2020 Q2 | 65,373 | 0.08 | Reduce 5.19% | <0.01 | $58.80 | $3,844,000 | SEC |
| 2020 Q1 | 68,953 | 0.08 | Reduce 40.17% | 0.04 | $55.73 | $3,843,000 | SEC |
| 2019 Q4 | 115,253 | 0.11 | Reduce 7.44% | <0.01 | $64.19 | $7,398,000 | SEC |
| 2019 Q3 | 124,512 | 0.09 | Add 2.90% | <0.01 | $50.71 | $6,314,000 | SEC |
| 2019 Q2 | 121,000 | 0.08 | Reduce 12.36% | 0.01 | $45.35 | $5,487,000 | SEC |
| 2019 Q1 | 138,060 | 0.09 | Buy | 0.09 | $47.71 | $6,587,000 | SEC |
| 2018 Q4 | 0 | 0.00 | Sell 100.00% | 0.12 | SEC | ||
| 2018 Q3 | 148,610 | 0.12 | Buy | 0.12 | $62.08 | $9,226,000 | SEC |
| 2006 Q3 | 0 | 0.00 | Sell 100.00% | 1.71 | SEC | ||
| 2006 Q2 | 4,841,000 | 1.71 | Add 40.32% | 0.49 | $25.86 | $125,188,000 | SEC |
| 2006 Q1 | 3,450,000 | 1.25 | Reduce 48.58% | 0.88 | $24.61 | $84,905,000 | SEC |
| 2005 Q4 | 6,709,400 | 1.82 | Add 320.20% | 1.39 | $22.98 | $154,182,000 | SEC |
| 2005 Q3 | 1,596,700 | 0.49 | Buy | 0.49 | $24.06 | $38,417,000 | SEC |
| 2002 Q4 | 0 | 0.00 | Sell 100.00% | 1.08 | SEC | ||
| 2002 Q3 | 2,913,900 | 1.08 | Buy | 1.08 | $23.80 | $69,351,000 | SEC |
| 2000 Q4 | 0 | 0.00 | Sell 100.00% | 3.15 | SEC | ||
| 2000 Q3 | 2,750,000 | 3.15 | Buy | 3.15 | $57.13 | $157,094,000 | SEC |